`biyobelirtecler` Related Article Results

Erisyon is a biotechnology company that has commercialized the world’s first single-molecule protein sequencing technology, pioneering a new era in proteomics with unmatched precision and scalability. The company’s platform, based on its proprietary Fluorosequencing method, enables direct, molecule-by-molecule analysis of proteins—offering powerful applications for early disease detection, diagnostics, and therapeutic development. Founding and Background Erisyon Inc. was founded in 2018 in the U

BPGbio is a biology-first, AI-powered, clinical-stage biopharmaceutical company focused on mitochondrial biology and protein homeostasis. The company integrates Bayesian causal artificial intelligence with experimental biology to accelerate drug discovery and development in oncology, rare diseases, and neurology. Its core technology, the proprietary NAi Interrogative Biology™ Platform, enables the identification of therapeutic targets, biomarkers, and drug candidates based on unbiased multi-omic

Tempus AI is a healthcare technology company developing artificial intelligence–driven precision medicine applications. By integrating clinical and molecular data into a comprehensive knowledge platform, Tempus enables physicians to make real-time, data-informed decisions. Its core mission is to ensure that every patient benefits from the experiences and data of those who came before, advancing personalized and targeted treatment strategies. History Tempus was founded in 2015 by Eric Lefkofsky a